Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.


Showing   of 11 results

CAR T illustration

UH Seidman Researchers Slash Time Needed to Produce CAR T-Cells

Quicker process will get needed therapy to cancer patients who don’t have time to wait - Innovations in Cancer | Fall 2022

CAR T illustration

Novel Strategy to Improve CAR T-cell Efficacy in Non-Hodgkin Lymphoma Revealed in Preclinical Studies

University Hospitals Seidman Cancer Center researchers part of team finding blocking a single receptor may combat T cell dysfunction associated with poor response to therapy - Innovations in Cancer | Summer 2022

Team Led by UH Seidman Cancer Center Researcher Develops and Validates Three-in-One CAR T Therapy

Approach detailed in the journal Nature Communications shows therapeutic potential of BAFF CAR T for treating multiple B cell cancers, using mouse models with high effectiveness and minimum side effects - Innovations in Cancer | Winter 2022

CAR T illustration

Anti-CD19 CAR T-Cells Produced Locally at UH Seidman Cancer Center Induce High Remission Rates in B-cell Malignancies, Study Finds

Clinical trials published in Nature Communications detail advantages of local approach - Innovations in Cancer | Fall 2021

CAR T illustration

Multiple Myeloma Patients at UH Seidman Cancer Center First in Ohio to Receive New CAR T-Cell Therapy

Patients also have access to promising clinical trial of vactosertib and pomalidomide - Innovations in Cancer | Summer 2021

Mesothelin - positive

New Immunotherapy Center at UH Seidman Cancer Center Sets the Stage for Solutions

Center offers dozens of clinical trials, including soon a rare all-human protein CAR T trial for patients with certain hematologic malignancies - Innovations in Cancer | Winter 2021

CAR T cells

More Specific Approach to CAR T Cell Therapy Shows Promise for B Cell Cancers

Investigational New Drug (IND) authorization is under way - Innovations in Cancer | Fall 2020

Local Manufacture of CAR T Cells Achieving Promising Results for Patients with High-Risk Lymphomas

UH Seidman Cancer Center team can culture cells in just eight days - Innovations in Cancer | Winter 2020

Results are loading...